PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey. Show more

400 ALEXANDER PARK DRIVE, PRINCETON, NJ, UNITED STATES, 08540, Princeton, NJ, 08540, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

64.8M

52 Wk Range

$1.02 - $1.88

Previous Close

$1.26

Open

$1.29

Volume

81,230

Day Range

$1.21 - $1.29

Enterprise Value

-23.92M

Cash

39.13M

Avg Qtr Burn

-19.68M

Insider Ownership

3.35%

Institutional Own.

67.41%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Rezatapopt (PC14586) Details Solid tumor/s	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rezatapopt (PC14586) (p53 reactivator) +/- azacitidine Details Acute myeloid leukemia	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rezatapopt/ PC14586 (p53 reactivator) + KEYTRUDA Details Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.